Facebook Linkedin RSS Twitter Youtube
Home 2023

Respiratory syncytial virus

StockWatch: Moderna’s Positive Phase III RSV Vaccine Data Wows Analysts
Drug Discovery

StockWatch: Moderna’s Positive Phase III RSV Vaccine Data Wows Analysts

Rapid Nanobait Test Detects Multiple Respiratory Viruses at the Same Time
Infectious Diseases

Rapid Nanobait Test Detects Multiple Respiratory Viruses at the Same Time

Adjuvanted Vaccine Protects Newborn Mice against Respiratory Syncytial Virus
Drug Discovery

Adjuvanted Vaccine Protects Newborn Mice against Respiratory Syncytial Virus

SARS-CoV-2 Infections Under the Nose of New Organoid Model
Coronavirus

SARS-CoV-2 Infections Under the Nose of New Organoid Model

RSV’s NS1 Protein Enters Nucleus to Sabotage Host’s Immune Response
News

RSV’s NS1 Protein Enters Nucleus to Sabotage Host’s Immune Response

In Vaccine Design, Artificial Proteins Start Mimicking Real Immunogens
Drug Discovery

In Vaccine Design, Artificial Proteins Start Mimicking Real Immunogens

Protein Corona Guides Viral Pathogenesis and Alzheimer Protein Aggregation
Featured

Protein Corona Guides Viral Pathogenesis and Alzheimer Protein Aggregation

Sanofi Plans Approval Filings for Cancer, Immunology Candidates
Industry News

Sanofi Plans Approval Filings for Cancer, Immunology Candidates

How Do Acute Viral Infections Turn Chronic?
Infectious Diseases

How Do Acute Viral Infections Turn Chronic?

25 Clinical Failures of Q1 2017
A-Lists

25 Clinical Failures of Q1 2017

123...6Page 2 of 6
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.